European Lead Factory Newsletter January 2015
The European Lead Factory Consortium is happy to present the latest issue of the “ELF Newsletter”, 01/2015.
Dortmund, 29.01.2015 ++++
It’s early 2015 and the latest European Lead Factory Newsletter is now out.
Take a look and discover interesting news and results of this unique European Drug Discovery initiative, such as:
- the 1st non ELF SME to receive a qualified hit list from the ELF
- the 1st publication on the character of the Joint European Compound Library (JECL)
- the celebration of almost 40.000 novel compounds synthesized and delivered into the JECL for HTS
- the upcoming ELF appearances at scientific meetings
Why not start thinking about submitting your target assay development and / or library design proposal?
Need more information?
Please contact the European Lead Factory via email at
- help@scaffold.europeanleadfactory.eu if you have questions with the submission of your novel library design proposal or
- info@europeanleadfactory.eu if you have questions with the submission of your high quality biology targets
Taros Chemicals is coordinating the Chemistry Consortium of the “European Lead Factory” drug discovery platform.
About Taros Chemicals
Taros is a privately owned discovery chemistry company, working with global pharmaceutical, biotech and chemical companies since 1999. Alongside our performance chemicals and material science division, Taros’ drug discovery mission is to create drug candidates as potential new medicines. Taros has a strong scientific track record on many biomolecular targets in all main therapeutic areas and thereby adding considerable value to collaborations from target validation and hit identification to lead generation and optimization. Taros’ core expertise ranges from custom synthesis and process development to modern medicinal and computational chemistry, as well as compound library design and production.
Taros was heading the chemistry efforts of the EUR 196 million funded European Lead Factory (2013-2018) and is currently heading its EUR 36.5 million funded continuation (2019-2022). Moreover, Taros is deeply engaged in other research alliances like the EUR 11 million funded Drug Discovery Hub Dortmund.
Press Contact:
Youri R. Mesmoudi, Executive Vice President, e-mail: innovation |at| taros.de
Are you going to attend the event? contact us in advance to arrange a personal meeting
Want to know more about this publication? Contact our scientists
Drug Discovery
Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…
custom chemical services
Custom Synthesis
We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…
Looks interesting?
As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia
Drug Discovery
Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…
Material Science
We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications…
Looks interesting?
As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia
Drug Discovery Chemistry
Medicinal Chemistry
In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area…
Discovery Chemistry
Custom Synthesis
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and…
